FDA Inspection 989069 — Pharmadax (Foshan) Co., Ltd.

Pharmadax (Foshan) Co., Ltd. — FEI 3008654992

The FDA completed an inspection of Pharmadax (Foshan) Co., Ltd. on Sep 23, 2016 in Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 23, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Foshan (China)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.